Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Weill currently holds 1,429 shares of TransMedics Group, Inc. (TMDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Weill has been a net seller of TMDX stock. They have purchased $325.0K and sold $3.4M worth of shares.
David Weill's most recent insider trade was on Mar 4, 2026, when they sold 3,571 shares at $0.00 per share.
David Weill serves as Executive at TransMedics Group, Inc. (TMDX). They have executed 17 insider transactions totaling $3.7M over their tenure at the company.
David Weill holds the position of Executive at TransMedics Group, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
David Weill has shown a selling trading pattern, with $325.0K in total purchases and $3.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Weill was on Nov 10, 2022, when they sold $1.2M worth of TMDX shares. This transaction involved 21,645 shares at $56.00 per share.
David Weill currently owns 1,429 shares of TransMedics Group, Inc. (TMDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Weill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Weill has 17 Form 4 filings on record as an insider at TransMedics Group, Inc..
Set alerts for David Weill and 40,000+ other insiders.